Vitamin D: Implications for ocular disease and therapeutic potential

Experimental Eye Research

Volumn 134, Issue , 2015, Pages 101-110

  Reins, Rose Y ^a   McDermott, Alison M ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

Anti inflammatory; Deficiency; Genetic variations; Ocular disease; Vitamin D

Indexed keywords

CALCIUM; VITAMIN D;

EYE DISEASES; HUMAN; IMMUNE SYSTEM; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VITAMIN D DEFICIENCY;

CALCIUM; EYE DISEASES; HUMANS; IMMUNE SYSTEM; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84939937179     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2015.02.019     Document Type: Review

References (125)

1. Adams J.S., Hewison M. Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase. Arch. Biochem. Biophys. 2012, 523:95-102. 10.1016/j.abb.2012.02.016.
2. Aksoy H., Akçay F., Kurtul N., Baykal O., Avci B. Serum 1,25 dihydroxy vitamin D (1,25(OH)2D3), 25 hydroxy vitamin D (25(OH)D) and parathormone levels in diabetic retinopathy. Clin. Biochem. 2000, 33:47-51.
3. Albert D.M., Marcus D.M., Gallo J.P., O'Brien J.M. The antineoplastic effect of vitamin D in transgenic mice with retinoblastoma. Investig. Ophthalmol. Vis. Sci. 1992, 33:2354-2364.
4. Albert D.M., Nickells R.W., Gamm D.M., Zimbric M.L., Schlamp C.L., Lindstrom M.J., Audo I. Vitamin D analogs, a new treatment for retinoblastoma: the first Ellsworth Lecture. Ophthalmic Genet. 2002, 23:137-156.
5. Albert D.M., Kumar A., Strugnell S.A., Darjatmoko S.R., Lokken J.M., Lindstrom M.J., Damico C.M., Patel S. Effectiveness of 1alpha-hydroxyvitamin D2 in inhibiting tumor growth in a murine transgenic pigmented ocular tumor model. Arch. Ophthalmol. 2004, 122:1365-1369. 10.1001/archopht.122.9.1365.
6. Albert D.M., Plum L.A., Yang W., Marcet M., Lindstrom M.J., Clagett-Dame M., DeLuca H.F. Responsiveness of human retinoblastoma and neuroblastoma models to a non-calcemic 19-nor vitamin D analog. J.Steroid Biochem. Mol. Biol. 2005, 97:165-172. 10.1016/j.jsbmb.2005.06.019.
7. Albert D.M., Scheef E.A., Wang S., Mehraein F., Darjatmoko S.R., Sorenson C.M., Sheibani N. Calcitriol is a potent inhibitor of retinal neovascularization. Investig. Ophthalmol. Vis. Sci. 2007, 48:2327-2334. 10.1167/iovs.06-1210.
8. Alsalem J.A., Patel D., Susarla R., Coca-Prados M., Bland R., Walker E.A., Rauz S., Wallace G.R. Characterization of vitamin d production by human ocular barrier cells. Investig. Ophthalmol. Vis. Sci. 2014, 55:2140-2147. 10.1167/iovs.13-13019.
9. Annamaneni S., Bindu C.H., Reddy K.P., Vishnupriya S. Association of vitamin D receptor gene start codon (Fok1) polymorphism with high myopia. Oman J. Ophthalmol. 2011, 4:57-62. 10.4103/0974-620X.83654.
10. Annweiler C., Milea D., Beauchet O. Dietary vitamin D and AMD. Ophthalmology 2012, 119:1090-1091. author reply 1091. 10.1016/j.ophtha.2012.02.005.
11. Artaza J.N., Norris K.C. Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J.Endocrinol. 2009, 200:207-221. 10.1677/JOE-08-0241.
12. Audo I., Darjatmoko S.R., Schlamp C.L., Lokken J.M., Lindstrom M.J., Albert D.M., Nickells R.W. Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma. Investig. Ophthalmol. Vis. Sci. 2003, 44:4192-4199.
13. Bouillon R., Carmeliet G., Verlinden L., van Etten E., Verstuyf A., Luderer H.F., Lieben L., Mathieu C., Demay M. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 2008, 29:726-776. 10.1210/er.2008-0004.
14. Bućan K., Ivanisević M., Zemunik T., Boraska V., Skrabić V., Vatavuk Z., Galetović D., Znaor L. Retinopathy and nephropathy in type 1 diabetic patients-association with polymorphysms of vitamin D-receptor, TNF, Neuro-D and IL-1 receptor 1 genes. Coll. Antropol. 2009, 33(Suppl.2):99-105.
15. Caspi R.R. Alook at autoimmunity and inflammation in the eye. J.Clin. Investig. 2010, 120:3073-3083. 10.1172/JCI42440.
16. Chang J.H., McCluskey P.J., Wakefield D. Acute anterior uveitis and HLA-B27. Surv. Ophthalmol. 2005, 50:364-388. 10.1016/j.survophthal.2005.04.003.
17. Chen W., Xu W., Tao Q., Liu J., Li X., Gan X., Hu H., Lu Y. Meta-analysis of the association of the HTRA1 polymorphisms with the risk of age-related macular degeneration. Exp. Eye Res. 2009, 89:292-300. 10.1016/j.exer.2008.10.017.
18. Choi H.S., Oh H.J., Choi H., Choi W.H., Kim J.G., Kim K.M., Kim K.J., Rhee Y., Lim S.-K. Vitamin D insufficiency in Korea-a greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008. J.Clin. Endocrinol. Metab. 2011, 96:643-651. 10.1210/jc.2010-2133.
19. Choi J.A., Han K., Park Y.-M., La T.Y. Low serum 25-hydroxyvitamin d is associated with myopia in korean adolescents. Investig. Ophthalmol. Vis. Sci. 2014, 55:2041-2047. 10.1167/IOVS.13-12853.
20. Cohen S.M., Saulenas A.M., Sullivan C.R., Albert D.M. Further studies of the effect of vitamin D on retinoblastoma. Inhibition with 1,25-dihydroxycholecalciferol. Arch. Ophthalmol. 1988, 106:541-543.
21. Coleman H.R., Chan C.-C., Ferris F.L., Chew E.Y. Age-related macular degeneration. Lancet 2008, 372:1835-1845. 10.1016/S0140-6736(08)61759-6.
22. Dang S.-T., Lu X.-H., Zhou J., Bai L. Effects of 1alpha, 25-dihydroxyvitamin D3 on the acute immune rejection and corneal neovascularization in high-risk penetrating keratoplasty in rats. Jun Yi Xue Xue Bao 2004, 24. Acad. J. First Med. Coll. PLA 892-896, 903.
23. Dawson D.G., Gleiser J., Zimbric M.L., Darjatmoko S.R., Lindstrom M.J., Strugnell S.A., Albert D.M. Toxicity and dose-response studies of 1-alpha hydroxyvitamin D2 in LH-beta-tag transgenic mice. Ophthalmology 2003, 110:835-839. 10.1016/S0161-6420(02)01934-6.
24. Day S., Acquah K., Platt A., Lee P.P., Mruthyunjaya P., Sloan F.A. Association of vitamin D deficiency and age-related macular degeneration in medicare beneficiaries. Arch. Ophthalmol. 2012, 130:1070-1071. 10.1001/archophthalmol.2012.439.
25. Dewan A., Liu M., Hartman S., Zhang S.S.-M., Liu D.T.L., Zhao C., Tam P.O.S., Chan W.M., Lam D.S.C., Snyder M., Barnstable C., Pang C.P., Hoh J. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006, 314:989-992. 10.1126/science.1133807.
26. DEWS The definition and classification of dry eye disease: report of the definition and classification subcommittee of the International Dry Eye WorkShop (2007). Ocul. Surf. 2007, 5:75-92.
27. Dulhunty A.F., Beard N.A., Pouliquin P., Kimura T. Novel regulators of RyR Ca2+ release channels: insight into molecular changes in genetically-linked myopathies. J.Muscle Res. Cell. Motil. 2006, 27:351-365. 10.1007/s10974-006-9086-1.
28. Elizondo R.A., Yin Z., Lu X., Watsky M.A. Effect of vitamin d receptor knockout on cornea epithelium wound healing and tight junctions. Investig. Ophthalmol. Vis. Sci. 2014, 55:5245-5251. 10.1167/iovs.13-13553.
29. Fang J., Hou S., Xiang Q., Qi J., Yu H., Shi Y., Zhou Y., Kijlstra A., Yang P. Polymorphisms in genetics of vitamin D metabolism confer susceptibility to ocular Behçet disease in a Chinese Han population. Am. J. Ophthalmol. 2014, 157:488-494. e6. 10.1016/j.ajo.2013.10.010.
30. Frampton R.J., Omond S.A., Eisman J.A. Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites. Cancer Res. 1983, 43:4443-4447.
31. French A.N., Ashby R.S., Morgan I.G., Rose K.A. Time outdoors and the prevention of myopia. Exp. Eye Res. 2013, 114:58-68. 10.1016/j.exer.2013.04.018.
32. Galor A., Gardener H., Pouyeh B., Feuer W., Florez H. Effect of a mediterranean dietary pattern and vitamin d levels on dry eye syndrome. Cornea 2014, 33:437-441. 10.1097/ICO.0000000000000089.
33. Golan S., Shalev V., Treister G., Chodick G., Loewenstein A. Reconsidering the connection between vitamin D levels and age-related macular degeneration. Eye 2011, 25:1122-1129. 10.1038/eye.2011.174.
34. Graffe A., Milea D., Annweiler C., Beauchet O., Mauget-Faÿsse M., Beauchet O., Kodjikian L., Milea D. Association between hypovitaminosis D and late stages of age-related macular degeneration: a case-control study. J.Am. Geriatr. Soc. 2012, 60:1367-1369. 10.1111/j.1532-5415.2012.04015.x.
35. Graffe A., Beauchet O., Fantino B., Milea D., Annweiler C. Vitamin d and macular thickness in the elderly: an optical coherence tomography study. Investig. Ophthalmol. Vis. Sci. 2014, 55:5298-5303. 10.1167/iovs.14-13918.
36. Gröber U., Spitz J., Reichrath J., Kisters K., Holick M.F. Vitamin D: update 2013: from rickets prophylaxis to general preventive healthcare. Dermatoendocrinol 2013, 5:331-347. 10.4161/derm.26738.
37. Gross C., Eccleshall T.R., Malloy P.J., Villa M.L., Marcus R., Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J.Bone Min. Res. 1996, 11:1850-1855. 10.1002/jbmr.5650111204.
38. Guggenheim J.A., Northstone K., McMahon G., Ness A.R., Deere K., Mattocks C., Pourcain B.S., Williams C. Time outdoors and physical activity as predictors of incident myopia in childhood: a prospective cohort study. Investig. Ophthalmol. Vis. Sci. 2012, 53:2856-2865. 10.1167/iovs.11-9091.
39. Guggenheim J.A., Williams C., Northstone K., Howe L.D., Tilling K., St Pourcain B., McMahon G., Lawlor D.A. Does vitamin d mediate the protective effects of time outdoors on myopia? Findings from a prospective birth cohort. Investig. Ophthalmol. Vis. Sci. 2014, 55:8550-8558. 10.1167/iovs.14-15839.
40. Guist G., Steffen C. Application and mechanism of high dosage of vitamin D therapy of glaucoma. Klin. Monbl. Augenheilkd. Augenärztl. Fortbild. 1953, 123:555-568.
41. Halder S.K., Goodwin J.S., Al-Hendy A. 1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells. J.Clin. Endocrinol. Metab. 2011, 96:E754-E762. 10.1210/jc.2010-2131.
42. Holick M.F. Vitamin D deficiency. N.Engl. J. Med. 2007, 357:266-281. 10.1056/NEJMra070553.
43. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., Murad M.H., Weaver C.M., Society Endocrine Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J.Clin. Endocrinol. Metab. 2011, 96:1911-1930. 10.1210/jc.2011-0385.
44. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium Dietary Reference Intakes for Calcium and Vitamin D, the National Academies Collection: Reports Funded by National Institutes of Health 2011, National Academies Press (US), Washington (DC).
45. Isik S., Ozuguz U., Tutuncu Y.A., Erden G., Berker D., Acar K., Aydin Y., Akbaba G., Helvaci N., Guler S. Serum transforming growth factor-beta levels in patients with vitamin D deficiency. Eur. J. Intern. Med. 2012, 23:93-97. 10.1016/j.ejim.2011.09.017.
46. Iyengar S.K., Song D., Klein B.E.K., Klein R., Schick J.H., Humphrey J., Millard C., Liptak R., Russo K., Jun G., Lee K.E., Fijal B., Elston R.C. Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am. J. Hum. Genet. 2004, 74:20-39. 10.1086/380912.
47. Johnson J.A., Grande J.P., Roche P.C., Campbell R.J., Kumar R. Immuno-localization of the calcitriol receptor, calbindin-D28k and the plasma membrane calcium pump in the human eye. Curr. Eye Res. 1995, 14:101-108.
48. Jones G., Prosser D.E., Kaufmann M. Cytochrome P450-mediated metabolism of vitamin D. J.Lipid Res. 2014, 55:13-31. 10.1194/jlr.R031534.
49. Jurutka P.W., Whitfield G.K., Hsieh J.C., Thompson P.D., Haussler C.A., Haussler M.R. Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev. Endocr. Metab. Disord. 2001, 2:203-216.
50. Kamen D.L., Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J.Mol. Med. 2010, 88:441-450. 10.1007/s00109-010-0590-9.
51. Kaur H., Donaghue K.C., Chan A.K., Benitez-Aguirre P., Hing S., Lloyd M., Cusumano J., Pryke A., Craig M.E. Vitamin D deficiency is associated with retinopathy in children and adolescents with type 1 diabetes. Diabetes Care 2011, 34:1400-1402. 10.2337/dc11-0103.
52. Kennel K.A., Drake M.T., Hurley D.L. Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin. Proc. 2010, 85:752-757. quiz 757-758. 10.4065/mcp.2010.0138.
53. Kift R., Berry J.L., Vail A., Durkin M.T., Rhodes L.E., Webb A.R. Lifestyle factors including less cutaneous sun exposure contribute to starkly lower vitamin D levels in U.K. South Asians compared with the white population. Br. J. Dermatol. 2013, 169:1272-1278. 10.1111/bjd.12518.
54. Kim S., Shevde N.K., Pike J.W. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J.Bone Min. Res. 2005, 20:305-317. 10.1359/JBMR.041112.
55. Kim E.C., Han K., Jee D. Inverse relationship between high blood 25-hydroxyvitamin D and late stage of age-related macular degeneration in a representative Korean population. Investig. Ophthalmol. Vis. Sci. 2014, 55:4823-4831. 10.1167/iovs.14-14763.
56. Krefting E.A., Jorde R., Christoffersen T., Grimnes G. Vitamin D and intraocular pressure - results from a case -control and an intervention study. Acta Ophthalmol. 2013, 92:345-349. 10.1111/aos.12125.
57. Krishnan A.V., Trump D.L., Johnson C.S., Feldman D. The role of vitamin D in cancer prevention and treatment. Endocrinol. Metab. Clin. North Am. 2010, 39:401-418. 10.1016/j.ecl.2010.02.011.
58. Kulkarni A.D., van Ginkel P.R., Darjatmoko S.R., Lindstrom M.J., Albert D.M. Use of combination therapy with cisplatin and calcitriol in the treatment of Y-79 human retinoblastoma xenograft model. Br. J. Ophthalmol. 2009, 93:1105-1108. 10.1136/bjo.2008.152843.
59. Kutuzova G.D., Gabelt B.T., Kiland J.A., Hennes-Beann E.A., Kaufman P.L., DeLuca H.F. 1α,25-Dihydroxyvitamin D(3) and its analog, 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D(3) (2MD), suppress intraocular pressure in non-human primates. Arch. Biochem. Biophys. 2012, 518:53-60. 10.1016/j.abb.2011.10.022.
60. Lee V., Rekhi E., Hoh Kam J., Jeffery G. Vitamin D rejuvenates aging eyes by reducing inflammation, clearing amyloid beta and improving visual function. Neurobiol. Aging 2012, 33:2382-2389. 10.1016/j.neurobiolaging.2011.12.002.
61. Lee Y.A., Kim H.Y., Hong H., Kim J.Y., Kwon H.J., Shin C.H., Yang S.W. Risk factors for low vitamin D status in Korean adolescents: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008-2009. Public Health Nutr. 2014, 17:764-771. 10.1017/S1368980013000438.
62. Leyssens C., Verlinden L., Verstuyf A. Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer. Endocr. Relat. Cancer 2013, 20:R31-R47. 10.1530/ERC-12-0381.
63. Lin Y., Ubels J.L., Schotanus M.P., Yin Z., Pintea V., Hammock B.D., Watsky M.A. Enhancement of vitamin D metabolites in the eye following vitamin D3 supplementation and UV-B irradiation. Curr. Eye Res. 2012, 37:871-878. 10.3109/02713683.2012.688235.
64. Lu X., Watsky M.A. Effects of vitamin D receptor knockout on cornea epithelium Gap junctions. Investig. Ophthalmol. Vis. Sci. 2014, 10.1167/iovs.13-13788.
65. Millen A.E., Voland R., Sondel S.A., Parekh N., Horst R.L., Wallace R.B., Hageman G.S., Chappell R., Blodi B.A., Klein M.L., Gehrs K.M., Sarto G.E., Mares J.A. Vitamin D status and early age-related macular degeneration in postmenopausal women. Arch. Ophthalmol. 2011, 129:481-489. CAREDS study group. 10.1001/archophthalmol.2011.48.
66. Mithal A., Wahl D.A., Bonjour J.-P., Burckhardt P., Dawson-Hughes B., Eisman J.A., El-Hajj Fuleihan G., Josse R.G., Lips P., Morales-Torres J. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos. Int. 2009, 20:1807-1820. IOF Committee of Sciecollab-auntific Advisors (CSA) Nutrition Working Group, J. Establ. Result Coop. Eur. Found. Osteoporos. Natl. Osteoporos. Found. USA. 10.1007/s00198-009-0954-6.
67. Morrison M.A., Silveira A.C., Huynh N., Jun G., Smith S.E., Zacharaki F., Sato H., Loomis S., Andreoli M.T., Adams S.M., Radeke M.J., Jelcick A.S., Yuan Y., Tsiloulis A.N., Chatzoulis D.Z., Silvestri G., Kotoula M.G., Tsironi E.E., Hollis B.W., Chen R., Haider N.B., Miller J.W., Farrer L.A., Hageman G.S., Kim I.K., Schaumberg D.A., DeAngelis M.M. Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum. Genomics 2011, 5:538-568.
68. Mutti D.O. Vitamin d may reduce the prevalence of myopia in korean adolescents. Investig. Ophthalmol. Vis. Sci. 2014, 55. 10.1167/iovs.14-14117.
69. Mutti D.O., Marks A.R. Blood levels of vitamin D in teens and young adults with myopia. Optom. Vis. Sci. 2011, 88:377-382. 10.1097/OPX.0b013e31820b0385.
70. Mutti D.O., Cooper M.E., Dragan E., Jones-Jordan L.A., Bailey M.D., Marazita M.L., Murray J.C., Zadnik K. Vitamin D receptor (VDR) and group-specific component (GC, vitamin D-binding protein) polymorphisms in myopia. Investig. Ophthalmol. Vis. Sci. 2011, 52:3818-3824. CLEERE Study Group. 10.1167/iovs.10-6534.
71. Nagakura K., Abe E., Suda T., Hayakawa M., Nakamura H., Tazaki H. Inhibitory effect of 1 alpha,25-dihydroxyvitamin D3 on the growth of the renal carcinoma cell line. Kidney Int. 1986, 29:834-840.
72. Nussenblatt R.B., Liu B., Li Z. Age-related macular degeneration: an immunologically driven disease. Curr. Opin. Investig. Drugs 2009, 2000(10):434-442.
73. Orton S.-M., Morris A.P., Herrera B.M., Ramagopalan S.V., Lincoln M.R., Chao M.J., Vieth R., Sadovnick A.D., Ebers G.C. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am. J. Clin. Nutr. 2008, 88:441-447.
74. Pahl L., Schubert S., Skawran B., Sandbothe M., Schmidtke J., Stuhrmann M. 1,25-Dihydroxyvitamin D decreases HTRA1 promoter activity in the rhesus monkey-a plausible explanation for the influence of vitamin D on age-related macular degeneration?. Exp. Eye Res. 2013, 116:234-239. 10.1016/j.exer.2013.09.012.
75. Parekh N., Chappell R.J., Millen A.E., Albert D.M., Mares J.A. Association between vitamin D and age-related macular degeneration in the Third National Health and Nutrition Examination Survey, 1988 through 1994. Arch. Ophthalmol. 2007, 125:661-669. 10.1001/archopht.125.5.661.
76. Payne J.F., Ray R., Watson D.G., Delille C., Rimler E., Cleveland J., Lynn M.J., Tangpricha V., Srivastava S.K. Vitamin D insufficiency in diabetic retinopathy. Endocr. Pract. 2012, 18:185-193. 10.4158/EP11147.OR.
77. Paz H.B., Tisdale A.S., Danjo Y., Spurr-Michaud S.J., Argüeso P., Gipson I.K. The role of calcium in mucin packaging within goblet cells. Exp. Eye Res. 2003, 77:69-75.
78. Petta S., Cammà C., Scazzone C., Tripodo C., Di Marco V., Bono A., Cabibi D., Licata G., Porcasi R., Marchesini G., Craxí A. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatol. Balt. Md. 2010, 51:1158-1167. 10.1002/hep.23489.
79. Picotto G., Liaudat A.C., Bohl L., Tolosa de Talamoni N. Molecular aspects of vitamin D anticancer activity. Cancer Investig. 2012, 30:604-614. 10.3109/07357907.2012.721039.
80. Plum L.A., DeLuca H.F. Vitamin D, disease and therapeutic opportunities. Nat. Rev. Drug Discov. 2010, 9:941-955. 10.1038/nrd3318.
81. Poon M., Craig M.E., Kaur H., Cusumano J., Sasongko M.B., Wong T.Y., Donaghue K.C. Vitamin D deficiency is not associated with changes in retinal geometric parameters in young people with type 1 diabetes. J.Diabetes Res. 2013, 2013:280691. 10.1155/2013/280691.
82. Prietl B., Treiber G., Pieber T.R., Amrein K. Vitamin D and immune function. Nutrients 2013, 5:2502-2521. 10.3390/nu5072502.
83. Prosser D.E., Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem. Sci. 2004, 29:664-673. 10.1016/j.tibs.2004.10.005.
84. Ramirez A.M., Wongtrakool C., Welch T., Steinmeyer A., Zügel U., Roman J. Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells. J.Steroid Biochem. Mol. Biol. 2010, 118:142-150. 10.1016/j.jsbmb.2009.11.004.
85. 1 in the retinas of rats with diabetes. Diabetes Res. Clin. Pract. 2012, 98:474-480. 10.1016/j.diabres.2012.09.028.
86. Rose K.A., Morgan I.G., Ip J., Kifley A., Huynh S., Smith W., Mitchell P. Outdoor activity reduces the prevalence of myopia in children. Ophthalmology 2008, 115:1279-1285. 10.1016/j.ophtha.2007.12.019.
87. Sabet S.J., Darjatmoko S.R., Lindstrom M.J., Albert D.M. Antineoplastic effect and toxicity of 1,25-dihydroxy-16-ene-23-yne-vitamin D3 in athymic mice with Y-79 human retinoblastoma tumors. Arch. Ophthalmol. 1999, 117:365-370.
88. Saulenas A.M., Cohen S.M., Key L.L., Winter C., Albert D.M. Vitamin D and retinoblastoma. The presence of receptors and inhibition of growth invitro. Arch. Ophthalmol. 1988, 106:533-535.
89. Schauber J., Gallo R.L. The vitamin D pathway: a new target for control of the skin's immune response?. Exp. Dermatol. 2008, 17:633-639. 10.1111/j.1600-0625.2008.00768.x.
90. Seddon J.M., Santangelo S.L., Book K., Chong S., Cote J. Agenomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am. J. Hum. Genet. 2003, 73:780-790. 10.1086/378505.
91. Seddon J.M., Reynolds R., Shah H.R., Rosner B. Smoking, dietary betaine, methionine, and vitamin D in monozygotic twins with discordant macular degeneration: epigenetic implications. Ophthalmology 2011, 118:1386-1394. 10.1016/j.ophtha.2010.12.020.
92. Sherwin J.C., Mackey D.A. Update on the epidemiology and genetics of myopic refractive error. Expert Rev. Ophthalmol. 2013, 8:63-87. 10.1586/eop.12.81.
93. Sherwin J.C., Reacher M.H., Keogh R.H., Khawaja A.P., Mackey D.A., Foster P.J. The association between time spent outdoors and myopia in children and adolescents: a systematic review and meta-analysis. Ophthalmology 2012, 119:2141-2151. 10.1016/j.ophtha.2012.04.020.
94. Shokravi M.T., Marcus D.M., Alroy J., Egan K., Saornil M.A., Albert D.M. Vitamin D inhibits angiogenesis in transgenic murine retinoblastoma. Investig. Ophthalmol. Vis. Sci. 1995, 36:83-87.
95. Shternfeld I.S., Lasudry J.G., Chappell R.J., Darjatmoko S.R., Albert D.M. Antineoplastic effect of 1,25-dihydroxy-16-ene-23-yne-vitamin D3 analogue in transgenic mice with retinoblastoma. Arch. Ophthalmol. 1996, 114:1396-1401.
96. Singh A., Falk M.K., Subhi Y., Sørensen T.L. The association between plasma 25-hydroxyvitamin D and subgroups in age-related macular degeneration: a cross-sectional study. PLoS One 2013, 8:e70948. 10.1371/journal.pone.0070948.
97. Singman E.L., Poon D., Jun A.S. Putative corneal neuralgia responding to vitamin d supplementation. Case Rep. Ophthalmol. 2013, 4:105-108. 10.1159/000354965.
98. Steinwender G., Lindner E., Weger M., Plainer S., Renner W., Ardjomand N., El-Shabrawi Y. Association between polymorphism of the vitamin D metabolism gene CYP27B1 and HLA-B27-associated uveitis. Is a state of relative immunodeficiency pathogenic in HLA B27-positive uveitis?. PLoS One 2013, 8:e62244. 10.1371/journal.pone.0062244.
99. Suárez F., Jockovich M.-E., Hernandez E., Feuer W., Parel J.-M., Murray T.G. Paclitaxel in the treatment of retinal tumors of LH beta-tag murine transgenic model of retinoblastoma. Investig. Ophthalmol. Vis. Sci. 2007, 48:3437-3440. 10.1167/iovs.06-0796.
100. Suhler E.B., Martin T.M., Rosenbaum J.T. HLA-B27-associated uveitis: overview and current perspectives. Curr. Opin. Ophthalmol. 2003, 14:378-383.
101. Suzuki T., Sano Y., Kinoshita S. Effects of 1alpha,25-dihydroxyvitamin D3 on Langerhans cell migration and corneal neovascularization in mice. Investig. Ophthalmol. Vis. Sci. 2000, 41:154-158.
102. Suzuki T., Sano Y., Sotozono C., Kinoshita S. Regulatory effects of 1alpha,25-dihydroxyvitamin D(3) on cytokine production by human corneal epithelial cells. Curr. Eye Res. 2000, 20:127-130.
103. Szyszka P., Zmijewski M.A., Slominski A.T. New vitamin D analogs as potential therapeutics in melanoma. Expert Rev. Anticancer Ther. 2012, 12:585-599. 10.1586/era.12.40.
104. Tang J., Zhou R., Luger D., Zhu W., Silver P.B., Grajewski R.S., Su S.-B., Chan C.-C., Adorini L., Caspi R.R. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J.Immunol. 2009, 1950(182):4624-4632. 10.4049/jimmunol.0801543.
105. Taverna M.J., Sola A., Guyot-Argenton C., Pacher N., Bruzzo F., Slama G., Reach G., Selam J.-L. Taq I polymorphism of the vitamin D receptor and risk of severe diabetic retinopathy. Diabetologia 2002, 45:436-442. 10.1007/s00125-001-0769-2.
106. Taverna M.J., Selam J.-L., Slama G. Association between a protein polymorphism in the start codon of the vitamin D receptor gene and severe diabetic retinopathy in C-peptide-negative type 1 diabetes. J.Clin. Endocrinol. Metab. 2005, 90:4803-4808. 10.1210/jc.2004-2407.
107. Tian Y., Wang C., Ye Z., Xiao X., Kijlstra A., Yang P. Effect of 1,25-dihydroxyvitamin D3 on Th17 and Th1 response in patients with Behçet's disease. Investig. Ophthalmol. Vis. Sci. 2012, 53:6434-6441. 10.1167/iovs.12-10398.
108. Tong Y., Liao J., Zhang Y., Zhou J., Zhang H., Mao M. LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: a HuGE review and meta-analysis. Mol. Vis. 2010, 16:1958-1981.
109. van Etten E., Verlinden L., Giulietti A., Ramos-Lopez E., Branisteanu D.D., Ferreira G.B., Overbergh L., Verstuyf A., Bouillon R., Roep B.O., Badenhoop K., Mathieu C. The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur. J. Immunol. 2007, 37:395-405. 10.1002/eji.200636043.
110. Verhoeff F.H. Retinoblastoma undergoing spontaneous regression. Calcifying agent suggested in treatment of retinoblastoma. Am. J. Ophthalmol. 1966, 62:573-574.
111. Verstappen A., Parmentier M., Chirnoaga M., Lawson D.E., Pasteels J.L., Pochet R. Vitamin D-dependent calcium binding protein immunoreactivity in human retina. Ophthalmic Res. 1986, 18:209-214.
112. Wagner N., Wagner K.-D., Schley G., Badiali L., Theres H., Scholz H. 1,25-dihydroxyvitamin D3-induced apoptosis of retinoblastoma cells is associated with reciprocal changes of Bcl-2 and bax. Exp. Eye Res. 2003, 77:1-9.
113. Wakefield D., Chang J.H., Amjadi S., Maconochie Z., Abu El-Asrar A., McCluskey P. What is new HLA-B27 acute anterior uveitis?. Ocul. Immunol. Inflamm. 2011, 19:139-144. 10.3109/09273948.2010.542269.
114. Wang T.-T., Tavera-Mendoza L.E., Laperriere D., Libby E., MacLeod N.B., Nagai Y., Bourdeau V., Konstorum A., Lallemant B., Zhang R., Mader S., White J.H. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol. Endocrinol. 2005, 19:2685-2695. 10.1210/me.2005-0106.
115. Wang Y., Wang V.M., Chan C.-C. The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment. Eye 2011, 25:127-139. 10.1038/eye.2010.196.
116. White J.H. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect. Immun. 2008, 76:3837-3843. 10.1128/IAI.00353-08.
117. Wilkerson C.L., Darjatmoko S.R., Lindstrom M.J., Albert D.M. Toxicity and dose-response studies of 1,25-(OH)2-16-ene-23-yne vitamin D3 in transgenic mice. Clin. Cancer Res. 1998, 4:2253-2256.
118. Windle J.J., Albert D.M., O'Brien J.M., Marcus D.M., Disteche C.M., Bernards R., Mellon P.L. Retinoblastoma in transgenic mice. Nature 1990, 343:665-669. 10.1038/343665a0.
119. Xue M.-L., Zhu H., Thakur A., Willcox M. 1 alpha,25-Dihydroxyvitamin D3 inhibits pro-inflammatory cytokine and chemokine expression in human corneal epithelial cells colonized with Pseudomonas aeruginosa. Immunol. Cell Biol. 2002, 80:340-345. 10.1046/j.1440-1711.80.4august.1.x.
120. Yang Z., Camp N.J., Sun H., Tong Z., Gibbs D., Cameron D.J., Chen H., Zhao Y., Pearson E., Li X., Chien J., Dewan A., Harmon J., Bernstein P.S., Shridhar V., Zabriskie N.A., Hoh J., Howes K., Zhang K. Avariant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006, 314:992-993. 10.1126/science.1133811.
121. Yazar S., Hewitt A.W., Black L.J., McKnight C.M., Mountain J.A., Sherwin J.C., Oddy W.H., Coroneo M.T., Lucas R.M., Mackey D.A. Myopia is associated with lower vitamin D status in young adults. Investig. Ophthalmol. Vis. Sci. 2014, 55:4552-4559. 10.1167/iovs.14-14589.
122. Yazici H., Fresko I., Yurdakul S. Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat. Clin. Pract. Rheumatol. 2007, 3:148-155. 10.1038/ncprheum0436.
123. Yin Z., Pintea V., Lin Y., Hammock B.D., Watsky M.A. Vitamin D enhances corneal epithelial barrier function. Investig. Ophthalmol. Vis. Sci. 2011, 52:7359-7364. 10.1167/iovs.11-7605.
124. Yoo T.K., Oh E., Hong S. Is vitamin D status associated with open-angle glaucoma? A cross-sectional study from South Korea. Public Health Nutr. 2014, 17:833-843. 10.1017/S1368980013003492.
125. Yoon K.-C., Mun G.-H., Kim S.-D., Kim S.-H., Kim C.Y., Park K.H., Park Y.J., S.-H., Song S.J., Shin J.P., Yang S.-W., Yu S.-Y., Lee J.S., Lim K.H., Park H.-J., Pyo E.-U., Yang J.-E., Kim Y.-T., Oh K.-W., Kang S.W. Prevalence of eye diseases in South Korea: data from the Korea National Health and Nutrition Examination Survey 2008-2009. Korean J. Ophthalmol. 2011, 25:421. 10.3341/kjo.2011.25.6.421.